View in EDS

Immune Mechanisms of Resistance to Cediranib in Ovarian Cancer.

Saved in:
Bibliographic Details
Title: Immune Mechanisms of Resistance to Cediranib in Ovarian Cancer.
Authors: Gopinathan G; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London, United Kingdom., Berlato C; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London, United Kingdom., Lakhani A; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London, United Kingdom., Szabova L; Frederick National Laboratory for Cancer Research, Tumour Microenvironment Leidos Biomedical Research Inc, Frederick, Maryland., Pegrum C; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London, United Kingdom., Pedrosa AR; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London, United Kingdom., Laforets F; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London, United Kingdom., Maniati E; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London, United Kingdom., Balkwill FR; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London, United Kingdom.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2022 Jun 01; Vol. 21 (6), pp. 1030-1043.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35313341
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immune Mechanisms of Resistance to Cediranib in Ovarian Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gopinathan+G%22">Gopinathan G</searchLink>; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Berlato+C%22">Berlato C</searchLink>; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lakhani+A%22">Lakhani A</searchLink>; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Szabova+L%22">Szabova L</searchLink>; Frederick National Laboratory for Cancer Research, Tumour Microenvironment Leidos Biomedical Research Inc, Frederick, Maryland.<br /><searchLink fieldCode="AU" term="%22Pegrum+C%22">Pegrum C</searchLink>; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pedrosa+AR%22">Pedrosa AR</searchLink>; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Laforets+F%22">Laforets F</searchLink>; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Maniati+E%22">Maniati E</searchLink>; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Balkwill+FR%22">Balkwill FR</searchLink>; Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London; London, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2022 Jun 01; Vol. 21 (6), pp. 1030-1043.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35313341
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-21-0689
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1030
    Titles:
      – TitleFull: Immune Mechanisms of Resistance to Cediranib in Ovarian Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gopinathan G
      – PersonEntity:
          Name:
            NameFull: Berlato C
      – PersonEntity:
          Name:
            NameFull: Lakhani A
      – PersonEntity:
          Name:
            NameFull: Szabova L
      – PersonEntity:
          Name:
            NameFull: Pegrum C
      – PersonEntity:
          Name:
            NameFull: Pedrosa AR
      – PersonEntity:
          Name:
            NameFull: Laforets F
      – PersonEntity:
          Name:
            NameFull: Maniati E
      – PersonEntity:
          Name:
            NameFull: Balkwill FR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2022 Jun 01
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1